Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) EBITDA Margin (2016 - 2023)

Historic EBITDA Margin for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to 431.51%.

  • Aethlon Medical's EBITDA Margin rose 284317000.0% to 431.51% in Q1 2023 from the same period last year, while for Mar 2023 it was 2072.12%, marking a year-over-year increase of 14704100.0%. This contributed to the annual value of 287.57% for FY2025, which is N/A changed from last year.
  • Aethlon Medical's EBITDA Margin amounted to 431.51% in Q1 2023, which was up 284317000.0% from 28863.21% recorded in Q1 2022.
  • Over the past 5 years, Aethlon Medical's EBITDA Margin peaked at 211.97% during Q4 2019, and registered a low of 28863.21% during Q1 2022.
  • For the 5-year period, Aethlon Medical's EBITDA Margin averaged around 5678.8%, with its median value being 1590.14% (2021).
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -222480300bps in 2022, then soared by 284317000bps in 2023.
  • Over the past 5 years, Aethlon Medical's EBITDA Margin (Quarter) stood at 211.97% in 2019, then plummeted by -85bps to 391.18% in 2020, then plummeted by -3675bps to 14768.63% in 2021, then crashed by -95bps to 28863.21% in 2022, then skyrocketed by 99bps to 431.51% in 2023.
  • Its EBITDA Margin stands at 431.51% for Q1 2023, versus 28863.21% for Q1 2022 and 14768.63% for Q4 2021.